No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4428187 |
chr3:69401248-69401249 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs2128973 |
chr3:69401260-69401261 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs550384760 |
chr3:69401309-69401310 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs149025074 |
chr3:69401381-69401382 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs1905474 |
chr3:69401394-69401395 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs9861135 |
chr3:69401399-69401400 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs192992434 |
chr3:69401459-69401460 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs569833203 |
chr3:69401490-69401491 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs17350402 |
chr3:69401498-69401499 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs184676864 |
chr3:69401500-69401501 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs578108690 |
chr3:69401502-69401503 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs13323667 |
chr3:69401503-69401504 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs187967620 |
chr3:69401524-69401525 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs142068196 |
chr3:69401528-69401529 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs147787045 |
chr3:69401564-69401565 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs192205879 |
chr3:69401578-69401579 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs528507495 |
chr3:69401651-69401652 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs141231384 |
chr3:69401673-69401674 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs565204784 |
chr3:69401690-69401691 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs531052029 |
chr3:69401710-69401711 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs550323220 |
chr3:69401764-69401765 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs567128954 |
chr3:69401767-69401768 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs573245803 |
chr3:69401782-69401783 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs539079185 |
chr3:69401785-69401786 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs1564758 |
chr3:69401786-69401787 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs1564757 |
chr3:69401804-69401805 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs553873519 |
chr3:69401822-69401823 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs374206677 |
chr3:69401832-69401833 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs566448825 |
chr3:69401842-69401843 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs544958035 |
chr3:69401849-69401850 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs538284405 |
chr3:69401893-69401894 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs368615496 |
chr3:69401900-69401901 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs558546907 |
chr3:69401902-69401903 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs542109437 |
chr3:69401919-69401920 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs568818421 |
chr3:69401941-69401942 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs146969375 |
chr3:69401953-69401954 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs184967323 |
chr3:69401962-69401963 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs138469020 |
chr3:69401984-69401985 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs561982327 |
chr3:69402000-69402001 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs74573438 |
chr3:69402068-69402069 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs553416487 |
chr3:69402072-69402073 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs574840779 |
chr3:69402085-69402086 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs767285 |
chr3:69402086-69402087 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs545041325 |
chr3:69402139-69402140 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs1010315 |
chr3:69402165-69402166 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs530869612 |
chr3:69402188-69402189 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs189288781 |
chr3:69402229-69402230 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs560740578 |
chr3:69402232-69402233 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs543067549 |
chr3:69402244-69402245 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs559119129 |
chr3:69402253-69402254 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|